207 related articles for article (PubMed ID: 11910313)
1. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Hori M
J Hypertens; 2002 Apr; 20(4):753-61. PubMed ID: 11910313
[TBL] [Abstract][Full Text] [Related]
2. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
3. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
[TBL] [Abstract][Full Text] [Related]
4. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
6. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats.
Nishikawa N; Masuyama T; Yamamoto K; Sakata Y; Mano T; Miwa T; Sugawara M; Hori M
J Am Coll Cardiol; 2001 Nov; 38(5):1539-45. PubMed ID: 11691537
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
[TBL] [Abstract][Full Text] [Related]
8. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction.
Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Miwa T; Hori M; Masuyama T
Cardiovasc Res; 2003 Mar; 57(3):757-65. PubMed ID: 12618237
[TBL] [Abstract][Full Text] [Related]
9. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Yoshida J; Miwa T; Sugawara M; Yamaguchi Y; Ookawara T; Suzuki K; Hori M
Cardiovasc Res; 2002 Jul; 55(1):76-82. PubMed ID: 12062710
[TBL] [Abstract][Full Text] [Related]
10. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats.
Oie E; Yndestad A; Robins SP; Børnerheim R; Asberg A; Attramadal H
Basic Res Cardiol; 2002 May; 97(3):239-47. PubMed ID: 12061394
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 and endothelin type A receptor antagonists modulate the extracellular matrix regulatory system differently in diastolic heart failure.
Yoshida J; Yamamoto K; Mano T; Sakata Y; Nishikawa N; Miwa T; Hori M; Masuyama T
J Hypertens; 2003 Feb; 21(2):437-44. PubMed ID: 12569276
[TBL] [Abstract][Full Text] [Related]
13. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
[TBL] [Abstract][Full Text] [Related]
15. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
[TBL] [Abstract][Full Text] [Related]
16. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
Kobayashi N; Hara K; Higashi T; Matsuoka H
Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
Sakata Y; Masuyama T; Yamamoto K; Nishikawa N; Yamamoto H; Kondo H; Ono K; Otsu K; Kuzuya T; Miwa T; Takeda H; Miyamoto E; Hori M
Circulation; 2000 Oct; 102(18):2269-75. PubMed ID: 11056104
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix.
Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Nakayama H; Otsu K; Suzuki K; Tada M; Hori M; Miwa T; Masuyama T
J Hypertens; 2003 Sep; 21(9):1737-45. PubMed ID: 12923407
[TBL] [Abstract][Full Text] [Related]
19. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.
Iwanaga Y; Kihara Y; Hasegawa K; Inagaki K; Yoneda T; Kaburagi S; Araki M; Sasayama S
Circulation; 1998 Nov; 98(19):2065-73. PubMed ID: 9808606
[TBL] [Abstract][Full Text] [Related]
20. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor.
Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Hori M; Miwa T; Masuyama T
Circulation; 2004 May; 109(17):2143-9. PubMed ID: 15051632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
